Marbofloxacin
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Marbofloxacin(F05645) |
2D Structure | |
FRCD ID | F05645 |
CAS Number | 115550-35-1 |
PubChem CID | 60651 |
Formula | C17H19FN4O4 |
IUPAC Name | None |
InChI Key | BPFYOAJNDMUVBL-UHFFFAOYSA-N |
InChI | InChI=1S/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25) |
Canonical SMILES | CN1CCN(CC1)C2=C(C=C3C4=C2OCN(N4C=C(C3=O)C(=O)O)C)F |
Isomeric SMILES | CN1CCN(CC1)C2=C(C=C3C4=C2OCN(N4C=C(C3=O)C(=O)O)C)F |
Synonyms | Marbofloxacine Marbofloxacin 115550-35-1 Zeniquin Marbocyl Marbofloxacine [INN-French] Marbofloxacinum [INN-Latin] Marbofloxacino [INN-Spanish] UNII-8X09WU898T BPFYOAJNDMUVBL-UHFFFAOYSA-N |
Classifies | Predicted: Plant Toxin |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Organoheterocyclic compounds |
Class | Quinolines and derivatives |
Subclass | Quinoline carboxylic acids |
Intermediate Tree Nodes | Not available |
Direct Parent | Quinoline carboxylic acids |
Alternative Parents |
|
Molecular Framework | Aromatic heteropolycyclic compounds |
Substituents | Quinoline-3-carboxylic acid - Fluoroquinolone - N-arylpiperazine - Aminoquinoline - Haloquinoline - Dihydroquinolone - Dihydroquinoline - Pyridine carboxylic acid - Pyridine carboxylic acid or derivatives - Tertiary aliphatic/aromatic amine - Dialkylarylamine - N-methylpiperazine - N-alkylpiperazine - 1,4-diazinane - Aryl halide - Aryl fluoride - Piperazine - Pyridine - Benzenoid - Heteroaromatic compound - Vinylogous amide - Amino acid or derivatives - Amino acid - Tertiary amine - Tertiary aliphatic amine - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Azacycle - Carboxylic acid - Oxacycle - Amine - Organopnictogen compound - Organic oxygen compound - Organic oxide - Organohalogen compound - Organofluoride - Organonitrogen compound - Organooxygen compound - Organic nitrogen compound - Hydrocarbon derivative - Aromatic heteropolycyclic compound |
Description | This compound belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 362.361 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Complexity | 636 |
Monoisotopic Mass | 362.139 |
Exact Mass | 362.139 |
XLogP | -0.5 |
Formal Charge | 0 |
Heavy Atom Count | 26 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB- | 0.9038 |
Human Intestinal Absorption | HIA+ | 0.9840 |
Caco-2 Permeability | Caco2+ | 0.6696 |
P-glycoprotein Substrate | Substrate | 0.7128 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7311 |
Non-inhibitor | 0.7908 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7863 |
Distribution | ||
Subcellular localization | Lysosome | 0.4781 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8964 |
CYP450 2D6 Substrate | Non-substrate | 0.8564 |
CYP450 3A4 Substrate | Substrate | 0.5141 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9026 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6635 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9280 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8104 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7696 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7516 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8492 |
Non-inhibitor | 0.7841 | |
AMES Toxicity | AMES toxic | 0.9107 |
Carcinogens | Non-carcinogens | 0.8054 |
Fish Toxicity | High FHMT | 0.9976 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9408 |
Honey Bee Toxicity | Low HBT | 0.8944 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7245 |
Carcinogenicity (Three-class) | Non-required | 0.6124 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.5251 | LogS |
Caco-2 Permeability | 1.1188 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.4016 | LD50, mol/kg |
Fish Toxicity | 1.1461 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.6464 | pIGC50, ug/L |
MRLs
Food | Product Code | Country | MRLs | Application Date | Notes |
---|---|---|---|---|---|
Milk | Japan | 0.08ppm | |||
Pig,Edible Offal | Japan | 0.2ppm | |||
Cattle,Edible Offal | Japan | 0.2ppm | |||
Pig,Kidney | Japan | 0.2ppm | |||
Cattle,Kidney | Japan | 0.2ppm | |||
Pig,Liver | Japan | 0.2ppm | |||
Cattle,Liver | Japan | 0.2ppm | |||
Pig,Fat | Japan | 0.05ppm | |||
Cattle,Fat | Japan | 0.05ppm | |||
Pig,Muscle | Japan | 0.2ppm | |||
Cattle,Muscle | Japan | 0.2ppm |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
Prevalence of most common human pathogenic Campylobacter spp. in dogs and cats inStyria, Austria. | Vet Med Sci | 2018 May | 29851311 |
Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia afterexperimental aerosol inoculation of nursery pigs. | Porcine Health Manag | 2018 Jun 22 | 29977591 |
Pharmacokinetics of marbofloxacin administered via intravenous regional limbperfusion in dairy cows: evaluation of two different tourniquets. | Vet Rec Open | 2017 Sep 26 | 29018533 |
Tissue distribution of marbofloxacin in pigs after a single intramuscularinjection. | J Vet Sci | 2017 Jun 30 | 27515270 |
Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulationof marbofloxacin, after intravenous and intramuscular administration to lactatinggoats. | J Vet Pharmacol Ther | 2017 Dec | 28470723 |
Efficient Reduction of Antibacterial Activity and Cytotoxicity of Fluoroquinolones by Fungal-Mediated N-Oxidation. | J Agric Food Chem | 2017 Apr 19 | 28365994 |
Determination of marbofloxacin in plasma and synovial fluid by ultrafiltrationfollowed by HPLC-MS/MS. | J Pharm Biomed Anal | 2016 May 10 | 26859613 |
A Liquid Chromatography-Tandem Mass Spectrometry Method for the Detection ofAntimicrobial Agents from Seven Classes in Calf Milk Replacers: Validation andApplication. | J Agric Food Chem | 2016 Mar 30 | 26971558 |
Use of micellar liquid chromatography to analyze oxolinic acid, flumequine,marbofloxacin and enrofloxacin in honey and validation according to the2002/657/EC decision. | Food Chem | 2016 Jul 1 | 26920300 |
Wildlife contamination with fluoroquinolones from livestock: Widespreadoccurrence of enrofloxacin and marbofloxacin in vultures. | Chemosphere | 2016 Feb | 26498102 |
Electrical field assisted matrix solid phase dispersion as a powerful tool toimprove the extraction efficiency and clean-up of fluoroquinolones in bovinemilk. | J Chromatogr A | 2016 Aug 26 | 27492598 |
Antibiotics and sweeteners in the aquatic environment: biodegradability,formation of phototransformation products, and in vitro toxicity. | Environ Sci Pollut Res Int | 2015 Nov | 26169816 |
Microbial screening for quinolones residues in cow milk by bio-optical method. | J Pharm Biomed Anal | 2015 Mar 15 | 25555518 |
Using deconvolution to understand the mechanism for variable plasmaconcentration-time profiles after intramuscular injection. | Int J Pharm | 2015 Mar 15 | 25636300 |
Luminescent determination of quinolones in milk samples by liquidchromatography/post-column derivatization with terbium oxide nanoparticles. | J Chromatogr A | 2015 Jul 31 | 26077970 |
Multiresidue determination of fluoroquinolones in poultry muscle and kidneyaccording to the regulation 2002/657/EC. A systematic comparison of two differentapproaches: Liquid chromatography coupled to high-resolution mass spectrometry ortandem mass spectrometry. | J Chromatogr A | 2015 Jan 30 | 25577647 |
Determination of fluoroquinolones in chicken feces - a new liquid-liquidextraction method combined with LC-MS/MS. | Environ Toxicol Pharmacol | 2014 Nov | 25305740 |
Comparison of different solid-phase extraction materials for the determination offluoroquinolones in chicken plasma by LC-MS/MS. | J Chromatogr B Analyt Technol Biomed Life Sci | 2014 Mar 1 | 24566266 |
Development of a novel genetically modified bioluminescent-bacteria-based assayfor detection of fluoroquinolones in animal-derived foods. | Anal Bioanal Chem | 2014 Dec | 25354889 |
Development of a highly sensitive and specific immunoassay for enrofloxacin basedon heterologous coating haptens. | Anal Chim Acta | 2014 Apr 11 | 24745749 |